Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1996; 76(04): 628-630
DOI: 10.1055/s-0038-1650634
DOI: 10.1055/s-0038-1650634
Letters to the Editor
Low Molecular Weight Heparin for Thromboprophylaxis during Pregnancy in 2 Patients with Mechanical Mitral Valve Replacement
Further Information
Publication History
Received 26 March 1996
Accepted after revision 28 May 1996
Publication Date:
10 July 2018 (online)
-
References
- 1 Hirsh J, Levine MN. Low Molecular Weight Heparin. Blood 1992; 79: 1-17
- 2 Hall RG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122-140
- 3 Flessa HC, Kopstrom AB, Glucck III, Will JJ. Placental transport of heparin. Am J Obstet Gynecol 1965; 93: 570-573
- 4 Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during longterm heparin treatment: A radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221-228
- 5 De Swiet M, Ward PD, Fidler J, Horsman A, Katz D, Letsky E, Peacock M, Wise PH. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol 1983; 90: 1129-1134
- 6 Cimo PL, Moake JL, Weinger RS, Ben Menachem YB, Khalis KG. Heparin-induced thrombocytopenia associated with platelet aggregating antibodies and arterial thrombosis. Am J Haematol 1979; 6: 125-133
- 7 Omri A, Delaloye JF, Anderson H, Bachmann F. Low Molecular Weight Heparin Novo (LHN-1) Does Not Cross the Placenta During the Second Trimester of Pregnancy. Thromb Haemost 1989; 1: 55-56
- 8 Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou C, Pemberton KD, Nicolaides KH, Barrett JJ, Kakkar VV. Use of Low Molecular Weight Heparin in Pregnancy. Thromb Haemost 1992; 68: 652-656
- 9 Nelson-Piercy C. Low molecular weight heparin for obstetric thromboprophylaxis. Br J Obstet Gynaecol 1994; 101: 6-8
- 10 Barradell LB, Buckley MM. Nadoparin Calcium. A Review of its Pharmacology and Clinical Applications in the Prevention and Treatment of Thromboembolic Disorders. Drugs 1992; 44: 858-888
- 11 Prandoni P, Lensing AWA, Buller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, Ten Cate JW. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339: 441-445
- 12 Lopaciuk S, Meissner AJ, Filipecki S, Zalwilska K, Sowier J, Ciesielski L, Bielawiec M, Glowinski S, Czestochowska E. and others. Subcutaneous Low Molecular Weight Heparin versus Subcutaneous Unfractionated Heparin in the Treatment od Deep Vein Thrombosis: a Polish Multicentre Trial. Thromb Haemost 1992; 68: 14-18
- 13 British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force. Guidelines on oral anticoagulation: Second edition. J Clin Pathol 1990; 43: 177-183
- 14 Hirsh J. Oral anticoagulation drugs. N Engl J Med 1991; 324: 1865-1875
- 15 Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women. Thromb Haemost 1990; 63: 319-320
- 16 Gillis S, Shushan A, Eldor A. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int J Gynecol Obstet 1992; 39: 297-301
- 17 Sturridge F, De Swiet M, Letsky E. The use of low molecular heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol 1994; 101: 69-71
- 18 Monreal M, Olive A, Lafoz E. Heparins, coumarin and bone density. Lancet 1991; 338: 706